|Articles|January 15, 2003

Major reversal: Vistakon to sell contact lenses on Internet

Jacksonville, FL-Vistakon has reversed a long-held policy and decided to sell its contact lenses directly to mail-order and Internet seller 1-800 Contacts.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!

Related Content

Aerie Pharmaceuticals CEO discusses what's new in the pipeline

ByDavid Hutton,OT Staff Reports

March 22nd 2022

John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting

ImprimisRx offers a look at three new products in the pipeline

ByDavid Hutton,Alex Delaney-Gesing

November 14th 2021

Making the grade: FDA approves first biosimilar product for retinal diseases

ByLynda Charters

November 1st 2021

Advancement in TED treatment is a bright spot

ByAndrew R. Harrison, MD

June 30th 2021

Comparable conscious sedation methods address individual patient needs

ByBret L. Fisher, MD

April 14th 2021

Major reversal: Vistakon to sell contact lenses on Internet

Newsletter

Related Content

Aerie Pharmaceuticals CEO discusses what's new in the pipeline

ImprimisRx offers a look at three new products in the pipeline

Making the grade: FDA approves first biosimilar product for retinal diseases

Advancement in TED treatment is a bright spot

Comparable conscious sedation methods address individual patient needs

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

FDA approvals in 2025: What changed and why it matters for ophthalmologists

Achieving a new level of refractive precision: Surgical strategies

What changed in glaucoma care in 2025: Surgeon perspective

Global trial equity: How LMIC data is reshaping US ophthalmology research

PRIMAvera study: Central vision improvement with subretinal implant